Skip to content

Jazz Pharmaceuticals JAZZ Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent

Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent at other companies

Flutter Entertainment logo
Flutter EntertainmentFLUT
$249.25M+280%
Xylem logo
XylemXYL
-$500K
Keysight Technologies logo
Keysight TechnologiesKEYS
-$63M0.0%
Caterpillar logo
CaterpillarCAT
-$20.25M-156%
Arch Capital Group logo
Arch Capital GroupACGL
$0
American Healthcare REIT logo
American Healthcare REITAHR

Other financials

Income statement

See full
Revenue$1.1B+19.1%
Operating income$336.6M+702%
Net income$293.1M+417%
EPS (diluted)$4.43+391%

Balance sheet

See full
Cash & equivalents$667.5M-64.1%
Total debt$5.4B-0.1%
Total equity$4.5B+8.6%
Total assets$11.9B+2.8%

Cash flow

See full
Operating cash flow$408.2M-5.0%
CapEx$19.7M+41.7%
Free cash flow$388.5M-6.6%

Valuation

See full
Market cap$14.11B+54.4%
Enterprise value$18.85B+47.7%
P/S3.2×+0.9×

Profitability

See full
Operating margin-11.9%-28.1pp
Net margin-8.9%-20.5pp
FCF margin28.6%-8.6pp

Returns & leverage

See full
Return on equity-9.1%-21.2pp
Debt / equity1.2×-0.1×
Current ratio-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent.

The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's other comprehensive income foreign currency transaction and translation adjustment net of tax portion attributable to parent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Jazz Pharmaceuticals's other comprehensive income foreign currency transaction and translation adjustment net of tax portion attributable to parent?
Jazz Pharmaceuticals (JAZZ) reported other comprehensive income foreign currency transaction and translation adjustment net of tax portion attributable to parent of -$82.7M in Q1 2026.
How has Jazz Pharmaceuticals's other comprehensive income foreign currency transaction and translation adjustment net of tax portion attributable to parent changed year-over-year?
Jazz Pharmaceuticals's other comprehensive income foreign currency transaction and translation adjustment net of tax portion attributable to parent decreased by 150.8% year-over-year, from $162.8M to -$82.7M.
What is the long-term trend for Jazz Pharmaceuticals's other comprehensive income foreign currency transaction and translation adjustment net of tax portion attributable to parent?
Over 3 years (2021 to 2025), Jazz Pharmaceuticals's other comprehensive income foreign currency transaction and translation adjustment net of tax portion attributable to parent has grown at a 12.3% compound annual growth rate (CAGR), from -$268.35M to $380.08M.
What does other comprehensive income foreign currency transaction and translation adjustment net of tax portion attributable to parent mean?
Gains or losses caused by changes in exchange rates when converting foreign business results into the reporting currency.
How do you interpret other comprehensive income foreign currency transaction and translation adjustment net of tax portion attributable to parent?
Positive values indicate a strengthening of foreign currencies against the reporting currency, while negative values indicate a weakening.
How does other comprehensive income foreign currency transaction and translation adjustment net of tax portion attributable to parent compare across companies?
Common for multinational corporations; varies based on global footprint and currency hedging strategies.